Serum levels of Hemorphin-7 peptides in patients with breast cancer

Clinica Chimica Acta

Volumn 337, Issue 1-2, 2003, Pages 59-67

  Cohen, Marie ^a   Fruitier Arnaudin, Ingrid ^a   Sauvan, Richard ^b   Birnbaum, Daniel ^b   Piot, Jean Marie ^a  

^a UNIVERSITÉ DE LA ROCHELLE   (France)

^b INSTITUT PAOLI CALMETTES   (France)

Author keywords

Breast cancer; Cathepsin; Diagnosis; Hemorphin; Serum

Indexed keywords

CATHEPSIN B; CATHEPSIN D; HEMORPHIN 7; PEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CARCINOMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

EID: 0142227007     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2003.07.011     Document Type: Article

References (31)

1. Zhao Q., Garreau I., Sannier F., Piot J.M. Opioid peptides derived from hemoglobin: hemorphins. Biopolymers. 43:1997;75-98.
2. Glämsta E.L., Meyerson B., Silberring J., Terenius L., Nyberg F. Isolation of a hemoglobin-derived opioid peptide from cerebrospinal fluid of patients with cerebrovascular bleedings. Biochem. Biophys. Res. Commun. 184:1992;1060-1066.
3. Duethman D., Dewan N., Conlon J.M. Isolation of the opioid peptide Leu-Val-Val-hemorphin-7 from bronchoalveolar lavage fluid of a patient with non-small cell lung cancer. Peptides. 21:2000;137-142.
4. Cerpa-Poljak A., Lahnstein J., Mason K.E., Smythe G.A., Duncan M.W. Mass spectrometric identification and quantification of hemorphins extracted from human adrenal and pheochromocytoma tissue. J. Neurochem. 68:1997;1712-1719.
5. Mäkinen K.K., Sewon L., Mäkinen P. Analysis in gingival crevicular fluid of two oligopeptides derived from human hemoglobin beta-chain. J. Periodontal Res. 31:1996;43-46.
6. Glämsta E.L., Morkrid L., Lantz I., Nyberg F. Concomitant increase in blood plasma levels of immunoreactive hemorphin-7 and beta-endorphin following long distance running. Regulatory Pept. 49:1993;9-18.
7. Fruitier I., Garreau I., Piot J.M. Cathepsin D is a good candidate for the specific release of a stable hemorphin from hemoglobin in vivo: VV-hemorphin-7. Biochem. Biophys. Res. Commun. 246:1998;719-724.
8. Brindley P.J., Kalinna B.H., Dalton J.P., Day S.R., Wong J.Y.M., Smythe M.L., McManus D.P. Proteolytic degradation of host hemoglobin by schistosomes. Mol. Biochem. Parasitol. 89:1997;1-9.
9. Kominami E., Ueno T., Muno D., Katunuma N. The selective role of cathepsins B and D in the lysosomal degradation of endogenous and exogenous proteins. FEBS Lett. 287:1991;189-192.
10. Rochefort H., Garcia M., Glondu M., Laurent V., Liaudet E., Rey J.M.et al. Cathepsin D in breast cancer: mechanisms and clinical applications, a 1999 overview. Clin. Chim. Acta. 291:2000;157-170.
11. Brouillet J.P., Dufour F., Lemany G., Garcia M., Schlup N., Grenier J.et al. Increased cathepsin D level in the serum of patients with metastatic breast carcinoma detected with a specific pro-cathepsin D immunoassay. Cancer. 79:1997;2132-2136.
12. Westhoff U., Fox C., Otto F. Quantification of Cathepsin D in plasma of patients with malignant melanoma. Anticancer Res. 18:1998;3785-3788.
13. Athanassiadou P., Sakellariou V., Michalas S., Petrakakou E., Athanassiades P., Aravantinos D. Immunocytochemical localization of Cathepsin D and CA 125 in ovarian cancer. Int. J. Gynaecol. Obstet. 56:1997;31-37.
14. Westley B.R., May F.E.B. Cathepsin D and breast cancer. Eur. J. Cancer. 32A:1996;15-24.
15. Foekens J.A., Look M.P., Bolt-de Vrie J., Meizer Van Gelder M.E., Van Putten W.L., Klyn J.G. Cathepsin D in primary breast cancer: prognostic evaluation involving 2810 patients. Br. J. Cancer. 79:1999;300-307.
16. Schultz D.C., Bazel S., Wright L.M., Tucker S., Lange M.K., Tachovsky T.et al. Western blotting and enzymatic activity analysis of cathepsin D in breast tissue and sera of patients with breast cancer and benign breast disease and of normal controls. Cancer Res. 54:1994;48-54.
17. Schwartz M.K. Tissue cathepsins as tumor markers. Clin. Chim. Acta. 237:1995;67-78.
18. Garreau I., Cucumel K., Dagouassat N., Zhao Q., Cupo A., Piot J.M. Hemorphin peptides are released from hemoglobin by cathepsin D. Radioimmunoassay against the C-part of V-V-hemorphin-7: an alternative assay for the cathepsin D activity. Peptides. 18:1997;293-300.
19. Zhao Q., Sannier F., Ricart G., Piot J.M. A rapid detection and identification of hemorphins released from bovine hemoglobin enzymatic hydrolysis by use of HPLC coupled with photodiode array detector. J. Liq. Chromatogr. 18:1995;93-103.
20. Zhao Q., Garreau I., Sannier F., Piot J.M. Identification of hemorphins from bovine hemoglobin hydrolysate: application of UV second order derivative spectroscopy. J. Liq. Chromatogr. 18:1995;1077-1092.
21. Cohen M., Fruitier-Arnaudin I., Garreau-Balandier I., Piot J.M. Quantification of hemorphin-7 peptides by enzyme linked immunosorbent assay with secondary antibody. Anal. Chim. Acta. 461:2002;229-233.
22. Koscielny S., Terrier P., Daver A., Wafflart J., Goussard J., Ricolleau G.et al. Quantitative determination of c-erbB-2 in human breast tumours: potential prognostic significance of low values. Eur. J. Cancer. 34:1998;476-481.
23. Katunuma N., Kominami E. Abnormal expression of lysosomal cysteine proteinases in muscle wasting diseases. Rev. Physiol., Biochem. Pharmacol. 108:1987;1-20.
24. Tumminello F.M., Leto G., Pizzolanti G., Candiloro V., Crescimanno M., Crosta L.et al. B and L circulating levels as prognostic markers of malignant progression. Anticancer Res. 16:1996;2315-2320.
25. Dagouassat N., Garreau I., Sannier F., Zhao Q., Piot J.M. Generation of VV-hemorphin-7 from globin by peritoneal macrophages. FEBS Lett. 382:1996;37-42.
26. Grunt T.W., Lametschwandtner A., Staindl O. The vascular pattern of basal cell tumors: light microscopy and scanning electron microscopic study on vascular corrosion casts. Microvasc. Res. 58:1988;236-244.
27. Deewhirst M.W., Tso C.Y., Secomb T.W., Gross J.F. Morphologic and hemodynamic comparison of tumor and healing normal tissue microvasculature. Int. J. Radiat. Oncol. Biol. Phys. 17:1989;91-99.
28. Shah-Yukich A.A., Nelson A.C. Characterisation of solid tumor microvasculature: a three-dimensional analysis using the polymer casting technique. Lab. Invest. 58:1988;236-244.
29. Mordan S., Devoiselle J.M., Maunoury V. In vivo pH measurement and imaging of tumor tissue using a pH-sensitive fluorescent probe (5,6-carboxyfluorescein): instrumental and experimental studies. Photochem. Photobiol. 60:1994;274-279.
30. Koblinski J.E., Ahram M., Sloane B.F. Unraveling the role of proteases in cancer. Clin. Chim. Acta. 291:2000;113-135.
31. Tamara T.L., Cercek M., Blejec A., Kos J., Gorodetsky E., Somers R.et al. Cathepsin B, a prognostic indicator in lymph node-negative breast carcinoma patients: comparison with cathepsin D, cathepsin L, and other clinical indicators. Clin. Cancer Res. 6:2000;578-584.